How I Do It: Identifying Signs to Differentiate Uterine Sarcoma (Leiomyosarcoma) from Leiomyomas at MRI
Radiology · 2026
DOI: 10.1148/radiol.252877 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Radiology, 2026. Verfasst von Nicole Hindman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, NYU Grossman School of Medicine, 660 First Ave, 3rd Fl, New York, NY 10016. Hauptthemen laut MEDLINE: Uterine Neoplasms, Leiomyosarcoma, Leiomyoma, Magnetic Resonance Imaging. Die Arbeit nennt 65 Literaturangaben.
Abstract (Originalsprache)
Contrast-enhanced MRI with diffusion-weighted imaging and apparent diffusion coefficient measurement is effective for stratifying the risk of uterine sarcoma in symptomatic patients, particularly for differentiating sarcomas like leiomyosarcoma from leiomyomas (uterine fibroids).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, NYU Grossman School of Medicine, 660 First Ave, 3rd Fl, New York, NY 10016.
- Department of Gynecology, NYU Grossman School of Medicine, New York, NY.
ORCID-Profile: Nicole Hindman, Angela Tong
Zitieren
APA
Hindman, N., Tong, A., & Huang, K. (2026). How I Do It: Identifying Signs to Differentiate Uterine Sarcoma (Leiomyosarcoma) from Leiomyomas at MRI. Radiology. https://doi.org/10.1148/radiol.252877
Vancouver
Hindman N, Tong A, Huang K. How I Do It: Identifying Signs to Differentiate Uterine Sarcoma (Leiomyosarcoma) from Leiomyomas at MRI. Radiology. 2026. doi:10.1148/radiol.252877
BibTeX
@article{Hindman2026,
author = {Hindman, Nicole and Tong, Angela and Huang, Kathy},
title = {How I Do It: Identifying Signs to Differentiate Uterine Sarcoma (Leiomyosarcoma) from Leiomyomas at MRI},
journal = {Radiology},
year = {2026},
doi = {10.1148/radiol.252877}
}
EUVIMED